GlassScriptPhysician profile
John F Ferguson
NPI 1841245560
$24,216.08
in general payments reported to CMS, 2019-2025
55 companies · $5,133 in 2025
The $5,133 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,100 · 2020: $1,689 · 2021: $2,076 · 2022: $3,744 · 2023: $3,884 · 2024: $4,590 · 2025: $5,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,020.51 |
| Education | $585.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,410.61 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Regeneron Healthcare Solutions, INC. | $2,811.35 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $2,004.07 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,376.05 | 2019-2025 | |
| Amgen INC. | $1,150.00 | 2021-2025 | Tezspire, Otezla, Repatha |
| Mylan Specialty L.P. | $1,001.50 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $920.81 | 2022-2025 | Glassia, Cuvitru, Hyqvia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $776.18 | 2019-2024 | Stiolto Respimat, Spiriva Respimat, Jardiance |
| Actelion Pharmaceuticals US, INC. | $714.03 | 2019-2025 | Uptravi, Opsumit |
| Insmed, INC. | $681.55 | 2019-2025 | Arikayce, Brinsupri |
| Novartis Pharmaceuticals Corporation | $573.98 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $507.07 | 2022-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $476.68 | 2021-2025 | Acthar |
| Sunovion Pharmaceuticals INC. | $464.40 | 2019-2021 | |
| Philips North America LLC | $444.78 | 2020-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $414.50 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $384.43 | 2020-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $363.59 | 2020-2025 | Xifaxan |
| Genentech USA, INC. | $348.69 | 2019-2024 | Xolair |
| Sanofi-Aventis U.S. LLC | $329.96 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $321.98 | 2021-2025 | Keytruda, Winrevair, Belsomra |
| United Therapeutics Corporation | $320.53 | 2021-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $314.57 | 2022-2025 | Wakix |
| Electromed, INC. | $278.39 | 2019-2025 | Smartvest |
| Viatris Specialty LLC | $208.02 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $194.32 | 2021-2024 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $188.49 | 2024 | Voquezna |
| Pfizer INC. | $182.42 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $173.85 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $150.80 | 2019-2025 | |
| Baxter Healthcare | $144.03 | 2022 | |
| Pulmonx Corporation | $142.19 | 2019 | |
| Mallinckrodt Enterprises LLC | $118.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.04 | 2019-2023 | |
| Axsome Therapeutics, INC. | $114.16 | 2022-2023 | Sunosi |
| E.R. Squibb & Sons, L.L.C. | $113.11 | 2019-2024 | Camzyos |
| Kowa Pharmaceuticals America, INC. | $111.80 | 2019-2020 | |
| Grifols USA, LLC | $99.95 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Amarin Pharma, INC. | $91.49 | 2019-2021 | |
| Shire North American Group INC | $82.47 | 2019 | |
| Novo Nordisk INC | $79.43 | 2019-2024 | Ozempic, Rybelsus |
| Covis Pharma Gmbh | $73.50 | 2022 | |
| Verona Pharma, INC. | $71.39 | 2025 | Ohtuvayre |
| Inogen, INC. | $69.67 | 2025 | |
| Inspire Medical Systems, INC. | $54.09 | 2024 | Inspire |
| Circassia INC. | $52.94 | 2019 | |
| Vifor Pharma, INC. | $52.07 | 2024-2025 | Zemaira |
| Lilly USA, LLC | $38.36 | 2023-2025 | Jardiance, Zepbound |
| Exact Sciences Corporation | $20.21 | 2025 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $15.59 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.19 | 2023 | Onpattro |
| Esperion Therapeutics, INC. | $15.03 | 2023 | Nexletol |
| Lupin INC. | $14.26 | 2019 | |
| Biogen, INC. | $11.72 | 2021 | |
| 3b Medical, INC. | $10.50 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.